Prosigna test in breast cancer: real-life experience

Author:

Hequet DORCID,Harrissart G,Krief D,Maumy L,Lerebours F,Menet E,Callens C,Rouzier R

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology

Reference26 articles.

1. Gradishar WJ, Anderson BO, Abraham J, Aft R, Agnese D, Allison KH, Blair SL, Burstein HJ, Dang C, Elias AD, Giordano SH, Goetz MP, Goldstein LJ, Isakoff SJ, Krishnamurthy J, Lyons J, Marcom PK, Matro J, Mayer IA, Moran MS, Mortimer J, O’Regan RM, Patel SA, Pierce LJ, Rugo HS, Sitapati A, Smith KL, Smith ML, Soliman H, Stringer-Reasor EM, Telli ML, Ward JH, Young JS, Burns JL, Kumar R (2020) Breast Cancer, Version 3.2020, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw. 18(4):452–478. https://doi.org/10.6004/jnccn.2020.0016

2. Loi S (2019) The ESMO clinical practise guidelines for early breast cancer: diagnosis, treatment and follow-up: on the winding road to personalized medicine. Ann Oncol 30(8):1183–1184. https://doi.org/10.1093/annonc/mdz201

3. Burstein HJ, Lacchetti C, Anderson H, Buchholz TA, Davidson NE, Gelmon KA, Giordano SH, Hudis CA, Solky AJ, Stearns V, Winer EP, Griggs JJ (2019) Adjuvant Endocrine Therapy for Women With Hormone Receptor-Positive Breast Cancer: ASCO Clinical Practice Guideline Focused Update. J Clin Oncol 37(5):423–438. https://doi.org/10.1200/JCO.18.01160

4. Vaz-Luis I, Cottu P, Mesleard C, Martin AL, Dumas A, Dauchy S, Tredan O, Levy C, Adnet J, Rousseau Tsangaris M, Andre F, Arveux P (2019) UNICANCER: French prospective cohort study of treatment-related chronic toxicity in women with localised breast cancer (CANTO). ESMO Open. https://doi.org/10.1136/esmoopen-2019-000562

5. de Jong N, Candel MJ, Schouten HC, Abu-Saad HH, Courtens AM (2005) Course of mental fatigue and motivation in breast cancer patients receiving adjuvant chemotherapy. Ann Oncol 16(3):372–382. https://doi.org/10.1093/annonc/mdi095 (Epub 2005 Jan 27 PMID: 15677622)

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3